FTC
Subscribe to FTC's Posts

FTC Dismisses Complaint in LabCorp

by Stephen Wu

Earlier today, the FTC dismissed its complaint against LabCorp after failing to obtain a preliminary injunction in federal district court to prevent LabCorp from further integrating with WestCliff. 

LabCorp had acquired WestCliff, a bankrupt lab services competitor in Southern California, in 2010, but the FTC chose to challenge the transaction in front of one of its administrative law judges and had sought a preliminary injunction from a federal district court to prevent LabCorp from integrating WestCliff pending the outcome of the administrative trial. 

After losing its bid for a preliminary injunction at the district court, the FTC filed an emergency motion for an injunction pending an appeal that the Ninth Circuit Court of Appeals denied.  This meant that LabCorp was free to integrate WestCliff pending the outcome of any appeal of the denial of the preliminary injunction or the FTC’s related administrative trial on the merits of the acquisition.

The FTC’s press release can be found at:  https://www.ftc.gov/opa/2011/04/labcorp.shtm.




read more

FTC and CFTC to Share Confidential Information, Increases Investigation Risks

by Jon B. DubrowGregory E. Heltzer, Blake H. Winbourne and Carrie G. Amezcua

The U.S. Federal Trade Commission and the U.S. Commodity Futures Trading Commission signed a memorandum of understanding that will facilitate the sharing of non-public information for “official law enforcement purposes,” and increase investigation risks for firms.

To read the full article, please visit: https://www.mwe.com/info/news/ots0411i.htm.




read more

The Top Five (Avoidable) Antitrust Traps in M&A Transactions

by Jon B. Dubrow, Joseph F. Winterscheid and Carla A. R. Hine

In M&A transactions, early involvement of antitrust counsel is essential to avoid unnecessary expense, delay and antitrust risks.  Failure to involve antitrust counsel early on in the process may not only jeopardize the parties’ ability to obtain antitrust clearance, but it can also give rise to potential exposure for independent antitrust violations and deal risk.  This article discusses five avoidable antitrust pitfalls to keep in mind early in any transaction planning process.

To read the full article, click here




read more

FTC Issues Preliminary Privacy Report, Seeks Comment from Stakeholders

by Heather Egan Sussman and Carla A. R. Hine

The U.S. Federal Trade Commission’s recently proposed framework for offline and online businesses and policymakers may have a significant impact on entities that collect, maintain and use consumer data.  The deadline for public comment is January 31, 2011.

To read the full article, please visit: https://www.mwe.com/info/news/ots1210e.htm.
 




read more

Market Definition Spurs District Court’s Decision Denying Product Ownership Challenge

by Jon B. Dubrow, David Marx, Jr. and Rachael Lewis

The Federal District Court in Minnesota recently decided Ovation Pharmaceutical did not violate federal or state antitrust laws when it acquired Indocin IV and NeoProfen, the only two drugs approved for treatment of a specific heart condition that primarily affects premature babies, because the challengers failed to establish that the drugs were in the same product market.  The decision raises significant issues to consider when evaluating antitrust risks in future transactions.

To read the full article, please visit: https://www.mwe.com/info/news/ots0910i.htm.
 




read more

BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

Ranked In Chambers USA 2022
US Leading Firm 2022